Control of interstitial fluid homeostasis: Roles of growth factors and integrins

Vascular Complications in Human Disease: Mechanisms and Consequences

Volumn , Issue , 2008, Pages 105-115

  Rubin, Kristofer ^a,b   Lidén, Åsa ^c   Van Wieringen, Tijs ^a   Reed, Rolf K ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350783301     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84628-919-4_8     Document Type: Chapter

References (57)

1. Aukland K, Reed RK. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 1993;73:1-78.
2. Dvorak HF. Discovery of vascular permeability factor (VPF). Exp Cell Res 2006;312:522-526.
3. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005;65:550-563.
4. Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005;437:497-504.
5. Rubin K, Gullberg D, Tomasini-Johansson B, Reed RK, Rydén C, Borg TK. Molecular recognition of the extracellular matrix by cell surface receptors. In: Comper WD, ed. Extracellular Matrix, Vol. 2, Molecular Components and Interactions. Reading, UK: Harwood Academic Publishers, 1996:262-309.
6. Reed RK, Berg A, Gjerde EA, Rubin K. Control of interstitial fluid pressure: role of β1-integrins. Semin Nephrol 2001;21:222-230.
7. Wiig H, Rubin K, Reed RK. New and active role of the interstitium in control of interstitial fluid pressure: potential therapeutic consequences. Acta Anaesthesiol Scand 2003;47:111-121.
8. Meyer FA. Macromolecular basis of globular protein exclusion and of swelling pressure in loose connective tissue (umbilical cord). Biochem Biophys Acta 1983;755:388-399.
9. Nedrebø T, Berg A, Reed RK. Effect of tumor necrosis factor-α, IL-1β, and IL-6 on interstitial fluid pressure in rat skin. Am J Physiol 1999;277:H1857-1862.
10. Berg A, Ekwall, AK, Rubin K, Stjernschantz J, Reed RK. Effect of PGE1, PGI2, and PGF2a analogs on collagen gel compaction in vitro and interstitial pressure in vivo. Am J Physiol 1998;274:H663-671.
11. Rodt SÅ, Reed RK, Ljungström M, Gustafsson TO, Rubin K. The anti-inflammatory agent a-trinositol exerts its edema-preventing effects through modulation of β1 integrin function. Circ Res 1994;75:942-948.
12. Shirakawa F, Yamashita U, Chedid M, Mizel SB. Cyclic AMP-an intracellular second messenger for interleukin 1. Proc Natl Acad Sci USA 1988;85:8201-8205.
13. Rodt SÅ, Åhlen K, Berg A, Rubin K, Reed RK. A novel physiological function for platelet-derived growth factor-BB in rat dermis. J Physiol (London) 1996;495:193-200.
14. Heuchel R, Berg A, Tallquist M, et al. Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling. Proc Natl Acad Sci USA 1999;96:11410-11415.
15. Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 2004;15:197-204.
16. Nedrebø T, Karlsen TV, Salvesen GS, Reed RK. A novel function of insulin in rat dermis. J Physiol 2004;559:583-591.
17. Åhlen K, Berg A, Stiger F, et al. Cell interactions with collagen matrices in vivo and in vitro depend on phosphatidylinositol 3-kinase and free cytoplasmic calcium. Cell Adhes Commun 1998;5:461-473.
18. Reed RK, Rubin K, Wiig H, Rodt SÅ. Blockade of β1-integrins in skin causes edema through lowering of interstitial fluid pressure. Circ Res 1992;71:978-983.
19. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-687.
20. Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 2002;4:E83-90.
21. Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell 1994;77:477-478.
22. Gullberg DE, Lundgren-Åkerlund E. Collagen-binding I domain integrins-what do they do? Prog Histochem Cytochem 2002;37:3-54.
23. Schwartz MA, Ginsberg MH. Networks and crosstalk: integrin signalling spreads. Nat Cell Biol 2002;4:E65-68.
24. Liden Å, Berg A, Nedrebø T, Reed RK, Rubin K. Platelet-derived growth factor BB-mediated normalization of dermal interstitial fluid pressure after mast cell degranulation depends on β3 but not β1 integrins. Circ Res 2006;98:635-641.
25. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 2003;13:264-269.
26. Harris AK, Stopak D, Wild P. Fibroblast traction as a mechanism for collagen morphogenesis. Nature 1981;290:249-251.
27. Balaban NQ, Schwarz US, Riveline D, et al. Force and focal adhesion assembly: a close relationship studied using elastic micropatterned substrates. Nat Cell Biol 2001;3:466-472.
28. Smilenov LB, Mikhailov A, Pelham RJ, Marcantonio EE, Gundersen GG. Focal adhesion motility revealed in stationary fibroblasts. Science 1999;286:1172-1174.
29. Gullberg D, Tingström A, Thuresson AC, et al. β1 Integrin-mediated collagen gel contraction is stimulated by PDGF. Exp Cell Res 1990;186:264-272.
30. Cukierman E, Pankov R, Stevens DR, Yamada KM. Taking cell-matrix adhesions to the third dimension. Science 2001;294:1708-1712.
31. Cooke ME, Sakai T, Mosher DF. Contraction of collagen matrices mediated by α2β1A and αVβ3 integrins. J Cell Sci 2000;113:2375-2383.
32. Grundström G, Mosher DF, Sakai T, Rubin K. Integrin aVb3 mediates plateletderived growth factor-BB-stimulated collagen gel contraction in cells expressing signaling deficient integrin α2β1. Exp Cell Res 2003;291:463-473.
33. Clark RA, Folkvord JM, Hart CE, Murray MJ, McPherson JM. Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices. J Clin Invest 1989;84:1036-1040.
34. Tingström A, Heldin C-H, Rubin K. Regulation of fibroblast-mediated collagen gel contraction by platelet-derived growth factor, interleukin-1a and transforming growth factor-β1. J Cell Sci 1992;102:315-322.
35. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-1659.
36. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-78.
37. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-337.
38. Jakobisiak M, Lasek W, Golab J. Natural mechanisms protecting against cancer. Immunol Lett 2003;90:103-122.
39. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002;196:254-265.
40. Voronov E, Shouval DS, Krelin Y, et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 2003;100:2645-2650.
41. Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994;271:58-65.
42. Gutmann R, Leunig M, Feyh J, et al. Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res 1992;52:1993-1995.
43. Brekken C, Hjelstuen MH, Bruland OS, deLange Davies C. Hyaluronidaseinduced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts. Anticancer Res 2000;20:3513-3519.
44. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987;47:3039-3051.
45. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 2000;60:4324-4327.
46. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
47. Tannock IF. Tumor physiology and drug resistance. Cancer Metastasis Rev 2001;20:123-132.
48. Rubin K, Sjöquist M, Gustafsson AM, Isaksson B, Salvessen G, Reed RK. Lowering of tumoral interstitial fluid pressure by prostaglandin E1 is paralleled by an increased uptake of 51Cr-EDTA. Int J Cancer 2000;86:636-643.
49. Emerich, DF, Snodgrass P, Dean RL, et al. Bradykinin modulation of tumor vasculature: I. Activation of B2 receptors increases delivery of chemotherapeutic agents into solid peripheral tumors, enhancing their efficacy. J Pharmacol Exp Ther 2001;296:623-631.
50. Pietras K, Östman A, Sjöquist M, et al. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 2001;61:2929-2934.
51. Lammerts E, Roswall P, Sundberg C, et al. Interference with TGF-κ1 and -β3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma. Int J Cancer 2002;102:453.462.
52. Lee CG, Heijn M, diTomaso E, et al. Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 2000;60:5565.5570.
53. Kristjansen PE, Boucher Y, Jain RK. Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft. Cancer Res 1993;53:4764-4766.
54. Salnikov AV, Iversen VV, Koisti M, et al. Lowering of tumor interstitial fluid pressure specifically augments efficacy of chemotherapy. FASEB J 2003;17:1756.1758.
55. Pietras K, Rubin K, Sjoblom T, et al. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res 2002;62:5476. 5484.
56. Willett CG. Boucher Y, DiTomaso E, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004;10:145.147.
57. Salnikov AV, Roswall P, Sundberg C, Gardner H, Heldin N-E, Rubin K. Inhibition of TGF-β modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma. Lab Invest 2005;85:512. 521.